Aptahem AB
Biotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Overview
- 1–4
- Employees
- ≤1K SEK
- Revenue
- 2014
- Founded
Key Decision Makers
Mikael Lindstam
CEO
Description
Aptahem is a specialized biotechnology company focused on developing novel RNA-based pharmaceuticals. Their primary mission is to create disruptive treatments for acute, life-threatening inflammatory diseases, such as sepsis. The company's lead drug candidate, Apta-1, is currently progressing throug...